UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Close relationship between the platelet activation marker CD62 and the granular release of platelet-derived growth factor

The Journal of pharmacology and experimental therapeutics, 2002-03, Vol.300 (3), p.952-957

2002

Volltextzugriff (PDF)

Successful Treatment of Catastrophic Antiphospholipid Antibody Syndrome (CAPS) Associated With Splenic Marginal-zone Lymphoma With Low-molecular Weight Heparin, Rituximab and Bendamustine

The American journal of the medical sciences, 2008-05, Vol.335 (5), p.394-397

2008

Volltextzugriff (PDF)

Oxidative stress and expression of p22phox are involved in the up‐regulation of tissue factor in vascular smooth muscle cells in response to activated platelets

The FASEB journal, 2000-08, Vol.14 (11), p.1518-1528

2000

Volltextzugriff (PDF)

Thrombin causes vascular endothelial growth factor expression in vascular smooth muscle cells: role of reactive oxygen species

Arteriosclerosis, thrombosis, and vascular biology, 2001-09, Vol.21 (9), p.1550-1555

2001

Volltextzugriff (PDF)

Pharmacodynamic characterization of the interaction between the glycoprotein IIb/IIIa inhibitor YM337 and unfractionated heparin and aspirin in humans

British journal of clinical pharmacology, 2003-09, Vol.56 (3), p.321-326

2003

Volltextzugriff (PDF)

Glanzmann thrombasthenia Frankfurt I is associated with a point mutation Thr176Ile in the N-terminal region of alpha IIb subunit integrin

Thrombosis and haemostasis, 2004-11, Vol.92 (5), p.1040

2004

Volltextzugriff (PDF)

Clinical assessment of potential fields of application of recombinant factor VIIa in internal and pediatric diseases. Recommendations of an expert group

Medizinische Klinik (München. 1983), 2007-01, Vol.102 (1), p.70-81

2007

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamic effects of a new antibody glycoprotein IIb/IIIa inhibitor (YM337) in healthy subjects

Circulation (New York, N.Y.), 1999-09, Vol.100 (11), p.1175-1181

1999

Volltextzugriff (PDF)

Differential in Vitro Effects of the Platelet Glycoprotein IIb/IIIa Inhibitors abixicimab or SR121566A on Platelet Aggregation, Fibrinogen Binding and Platelet Secretory Parameters

Thrombosis research, 2000-02, Vol.97 (4), p.201-207

2000

Volltextzugriff (PDF)

Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects

British journal of clinical pharmacology, 2001-09, Vol.52 (3), p.297-305

2001

Volltextzugriff (PDF)

21 - Hämostase

Internistische Therapie 2022 • 2023, 2022, p.865-884

24th Edition, 2022

Volltextzugriff (PDF)

Platelet Glycoprotein Expression in Patients with Myelodysplastic Syndrome

Thrombosis research, 2000-10, Vol.100 (1), p.27-34

2000

Volltextzugriff (PDF)

Oxidative stress and expression of p22phox are involved in the up-regulation of tissue factor in vascular smooth muscle cells in response to activated platelets

The FASEB journal, 2000-08, Vol.14 (11), p.1518-1528

2000

Volltextzugriff (PDF)

Antidotal Effects of rFVIIa and FEIBA on Anticoagulant-Induced Inhibition of Thrombin Generation

Blood, 2006-11, Vol.108 (11), p.4124-4124

2006

Volltextzugriff (PDF)

Thrombin-induced interleukin 1β synthesis in platelet suspensions: Impact of contaminating leukocytes

Platelets (Edinburgh), 2007-01, Vol.18 (2), p.119-127

2007

Volltextzugriff (PDF)

Ex vivo-in vitro interaction between aspirin, clopidogrel, and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566A

Clinical pharmacology and therapeutics, 2000-03, Vol.67 (3), p.305-313

2000

Volltextzugriff (PDF)

Testing for inherited platelet defects in clinical laboratories in Germany, Austria and Switzerland. Results of a survey carried out by the Permanent Paediatric Group of the German Thrombosis and Haemostasis Research Society (GTH)

Platelets (Edinburgh), 2010-09, Vol.21 (6), p.470-478

2010

Volltextzugriff (PDF)

rFVIIa Treatment and Efficacy Prediction in a Patient with Hermansky-Pudlak Syndrome Type 1 (HPS-1) Using Global Clotting Tests and Flow Cytometry

Blood, 2005-11, Vol.106 (11), p.4019-4019

2005

Volltextzugriff (PDF)

Klinische Bewertung potentieller Einsatzbereiche von rekombinantem Faktor VIIa bei internistischen und pädiatrischen Erkrankungen: Empfehlungen einer Expertengruppe

Medizinische Klinik (München. 1983), 2007-01, Vol.102 (1), p.70-81

2007

Volltextzugriff (PDF)

Aggregating human platelets stimulate the expression of thrombin receptors in cultured vascular smooth muscle cells via the release of transforming growth factor-beta(1) and platelet-derived growth factor(AB)

Circulation (New York, N.Y.), 1997-12, Vol.96 (11), p.3888

1997

Volltextzugriff (PDF)

Glanzmann thrombasthenia Frankfurt I is associated with a point mutation Thr176Ile in the N-terminal region of αIIb subunit integrin

Thrombosis and haemostasis, 2004, Vol.92 (11), p.1040-1051

2004

Volltextzugriff (PDF)

Factor VIII Efficacy and Tissue Factor Levels in Hemophilia A Patients Undergoing Total Knee Replacement

Blood, 2004-11, Vol.104 (11), p.4029-4029

2004

Volltextzugriff (PDF)

Thrombin-induced interleukin 1beta synthesis in platelet suspensions: impact of contaminating leukocytes

Platelets (Edinburgh), 2007-03, Vol.18 (2), p.119-127

2007

Volltextzugriff (PDF)

Monitoring of FVIII Replacement Therapy with Cell-Based Monitoring Tests

Blood, 2004-11, Vol.104 (11), p.3098-3098

2004

Volltextzugriff (PDF)

Aggregating human platelets stimulate expression of vascular endothelial growth factor in cultured vascular smooth muscle cells through a synergistic effect of transforming

Circulation (New York, N.Y.), 1999-08, Vol.100 (8), p.855

1999

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(23)

Publikationsform

Sprache

Englisch
(27)
Deutsch
(6)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Close relationship between the platelet activation marker CD62 and the granular release of platelet-derived growth factor

Successful Treatment of Catastrophic Antiphospholipid Antibody Syndrome (CAPS) Associated With Splenic Marginal-zone Lymphoma With Low-molecular Weight Heparin, Rituximab and Bendamustine

Oxidative stress and expression of p22phox are involved in the up‐regulation of tissue factor in vascular smooth muscle cells in response to activated platelets

Thrombin causes vascular endothelial growth factor expression in vascular smooth muscle cells: role of reactive oxygen species

Pharmacodynamic characterization of the interaction between the glycoprotein IIb/IIIa inhibitor YM337 and unfractionated heparin and aspirin in humans

Glanzmann thrombasthenia Frankfurt I is associated with a point mutation Thr176Ile in the N-terminal region of alpha IIb subunit integrin

Clinical assessment of potential fields of application of recombinant factor VIIa in internal and pediatric diseases. Recommendations of an expert group

Pharmacokinetics and pharmacodynamic effects of a new antibody glycoprotein IIb/IIIa inhibitor (YM337) in healthy subjects

Differential in Vitro Effects of the Platelet Glycoprotein IIb/IIIa Inhibitors abixicimab or SR121566A on Platelet Aggregation, Fibrinogen Binding and Platelet Secretory Parameters

Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects

21 - Hämostase

Platelet Glycoprotein Expression in Patients with Myelodysplastic Syndrome

Oxidative stress and expression of p22phox are involved in the up-regulation of tissue factor in vascular smooth muscle cells in response to activated platelets

Antidotal Effects of rFVIIa and FEIBA on Anticoagulant-Induced Inhibition of Thrombin Generation

Thrombin-induced interleukin 1β synthesis in platelet suspensions: Impact of contaminating leukocytes

Ex vivo-in vitro interaction between aspirin, clopidogrel, and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566A

Testing for inherited platelet defects in clinical laboratories in Germany, Austria and Switzerland. Results of a survey carried out by the Permanent Paediatric Group of the German Thrombosis and Haemostasis Research Society (GTH)

rFVIIa Treatment and Efficacy Prediction in a Patient with Hermansky-Pudlak Syndrome Type 1 (HPS-1) Using Global Clotting Tests and Flow Cytometry

Klinische Bewertung potentieller Einsatzbereiche von rekombinantem Faktor VIIa bei internistischen und pädiatrischen Erkrankungen: Empfehlungen einer Expertengruppe

Aggregating human platelets stimulate the expression of thrombin receptors in cultured vascular smooth muscle cells via the release of transforming growth factor-beta(1) and platelet-derived growth factor(AB)

Glanzmann thrombasthenia Frankfurt I is associated with a point mutation Thr176Ile in the N-terminal region of αIIb subunit integrin

Factor VIII Efficacy and Tissue Factor Levels in Hemophilia A Patients Undergoing Total Knee Replacement

Thrombin-induced interleukin 1beta synthesis in platelet suspensions: impact of contaminating leukocytes

Monitoring of FVIII Replacement Therapy with Cell-Based Monitoring Tests

Aggregating human platelets stimulate expression of vascular endothelial growth factor in cultured vascular smooth muscle cells through a synergistic effect of transforming

Suchergebnisse filtern